Medicaid now covers genetic testing for sick children—a diagnostic breakthrough for rare diseases.
S. 5719 — Genomic Answers for Children’s Health Act of 2026 · Filed by Roger Wicker (R-MS) · 3 cosponsors · Introduced Nov 16, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires Medicaid to cover whole genome and whole exome sequencing (genetic tests that read a child's full or partial DNA) for children suspected of having genetic disorders, rare diseases, or conditions of unknown origin—including developmental delays and intellectual disabilities. It mandates that these tests be paid separately (not bundled into other medical payments), requires the federal government to educate states and providers about the coverage, and directs studies on implementation barriers and outcomes.
Why we flagged it
The bill's core mechanism is a straightforward expansion of Medicaid's covered services to include whole genome and whole exome sequencing for children with suspected genetic or rare diseases. It is a public health measure, not a tax provision, appropriation, or regulatory carve-out.
What the text implies
- Genetic testing access may create disparities if state Medicaid programs implement inconsistently; the bill's outreach and reporting provisions attempt to mitigate this but do not mandate uniform standards.
- Prior authorization and administrative barriers remain a concern; the bill directs study of these but does not prohibit them, leaving room for states to delay or deny claims.
- Genetic counselor workforce shortages and reimbursement gaps are identified as a problem but not directly addressed; the bill studies the issue but does not fund training or mandate payment rates.
- The bill's reliance on state legislative action for compliance creates a compliance timeline risk; states with biennial legislatures may delay implementation by up to two years.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Medicaid-eligible children with suspected genetic or rare diseases gain access to potentially life-changing diagnostic testing at no out-of-pocket cost. The bill removes a coverage barrier and mandates separate payment to prevent denial through bundling, directly expanding a public health benefit to a vulnerable population.
Who stands to gain
- clinical laboratory companies and genetic testing providers
- pediatric hospitals and children's health systems
- genetic counseling services
Named in the bill
Medicaid (Title XIX, Social Security Act), Department of Health and Human Services, Comptroller General of the United States, State Medicaid programs, pediatricians, pediatric rare disease specialists, children's hospitals, genetic counselors, laboratory test developers
Where it stands
3 cosponsors: 2 Democrats, 1 Republicans.
- Nov 16, 2026 — Introduced · Congress.gov: “Introduced in Senate”
- Nov 16, 2026 — Referred to Senate Committee on Finance · Congress.gov: “Read twice and referred to the Committee on Finance”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (6,977 characters) on Nov 19, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-11-22.
“Medicaid now covers genetic testing for sick children—a diagnostic breakthrough for rare diseases.” QuorumCivic. https://share.quorumcivic.app/bill/119/s5719 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.